MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
8.31
+0.41
+5.19%
Closed 16:00 11/07 EST
OPEN
8.06
PREV CLOSE
7.90
HIGH
8.50
LOW
8.01
VOLUME
9.13K
TURNOVER
--
52 WEEK HIGH
13.20
52 WEEK LOW
6.65
MARKET CAP
563.71M
P/E (TTM)
-296.7857
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHAR last week (1028-1101)?
Weekly Report · 3d ago
Pharming Group Price Target Cut to $30.00/Share From $31.00 by Oppenheimer
Dow Jones · 10/28 12:56
Pharming Group Is Maintained at Outperform by Oppenheimer
Dow Jones · 10/28 12:56
Oppenheimer Maintains Outperform on Pharming, Lowers Price Target to $30
Benzinga · 10/28 12:45
Pharming price target lowered to $30 from $31 at Oppenheimer
TipRanks · 10/28 12:00
Weekly Report: what happened at PHAR last week (1021-1025)?
Weekly Report · 10/28 10:26
Pharming Group Price Target Maintained With a $37.00/Share by HC Wainwright & Co.
Dow Jones · 10/24 19:24
HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target
Benzinga · 10/24 19:14
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group N.V. stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.